中国公司正在掀起新一轮收购狂潮,并因此备受国际瞩目。但专家提醒——中国公司正在掀起新一轮收购狂潮,并因此越来越受到国际瞩目。中国最大的药品制造商三九企业集团收购了日本中型制药企业东亚制药51%的股权,以此绕过各种壁垒直接进入日本市场,开辟了我国医药企业并购国外药 Chinese companies are setting off a new round of acquisition frenzy, and thus has attracted international attention. However, experts advise - Chinese companies are setting off a new round of acquisition frenzy, and therefore more and more by the international attention. China's largest pharmaceutical manufacturer Sanjiu Enterprise Group acquired a 51% stake in Japan's medium-sized pharmaceutical company Asahi Pharmaceutical, bypassing the various barriers to direct access to the Japanese market, opened up China's pharmaceutical companies mergers and acquisitions of foreign drugs